treatment options

Treatment Preferences for Subcutaneous Immunoglobulin Among Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Caregivers, and Physicians: A Discrete Choice Experiment

Treatment Preferences The exploration of treatment preferences for subcutaneous immunoglobulin (SCIg) among individuals diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP),

Treatment Preferences for Subcutaneous Immunoglobulin Among Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Caregivers, and Physicians: A Discrete Choice Experiment Read Post »

Scroll to Top